Both these MBCs were from BRCA1/2 mutation negative patients with no family history of BC, were invasive ductal carcinomas, and presented with high grade (G3), ER-positive, HER2-negative and lymph node positive status. Here, ERBB2 is linked to invasive ductal breast carcinoma.